Get the Stockscreener App
2.3565
1.57%
0.0365
Aytu Biopharma Inc stock is traded at $2.3565, with a volume of 9,707.
It is up +1.57% in the last 24 hours and up +7.11% over the past month.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
See More
Previous Close:
$2.32
Open:
$2.32
24h Volume:
9,707
Relative Volume:
0.07
Market Cap:
$21.15M
Revenue:
$93.76M
Net Income/Loss:
$-13.68M
P/E Ratio:
-0.896
EPS:
-2.63
Net Cash Flow:
$8.77M
1W Performance:
+2.46%
1M Performance:
+7.11%
6M Performance:
+99.70%
1Y Performance:
-4.60%
1-Day Range:
$2.32
$2.3747
1-Week Range:
$2.29
$2.58
52-Week Range:
$0.95
$2.85
Aytu Biopharma Inc Stock (AYTU) Company Profile
Name
Aytu Biopharma Inc
Sector
Phone
(720) 437-6580
Address
7900 E. UNION AVENUE, DENVER
Compare AYTU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.3565 | 20.83M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
147.28 | 65.12B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.04 | 47.66B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.29 | 42.03B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.44 | 21.08B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
407.07 | 18.26B | 2.99B | 1.21B | 1.13B | 25.06 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Initiated | Lake Street | Buy |
| Jun-30-25 | Initiated | Ascendiant Capital Markets | Buy |
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-29-20 | Initiated | H.C. Wainwright | Buy |
Aytu Biopharma Inc Stock (AYTU) Latest News
What high frequency data says about Aytu BioPharma Inc.Market Sentiment Summary & Verified Technical Trade Signals - newser.com
Chart based analysis of Aytu BioPharma Inc. trendsJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
Visualizing Aytu BioPharma Inc. stock with heatmapsTake Profit & Risk Controlled Stock Pick Alerts - newser.com
How to read the order book for Aytu BioPharma Inc.Quarterly Market Review & Free High Return Stock Watch Alerts - newser.com
Using fundamentals and technicals on Aytu BioPharma Inc.Jobs Report & Weekly Momentum Stock Picks - newser.com
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025 - ACCESS Newswire
CNS Drug Developer Aytu BioPharma Announces Q4 and Full Year 2025 Earnings Date & Conference Call - Stock Titan
History Review: Will Aytu BioPharma Inc benefit from rising consumer demand2025 Winners & Losers & Intraday High Probability Alerts - خودرو بانک
Aytu BioPharma Inc. stock trendline breakdown2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Trend analysis for Aytu BioPharma Inc. this weekSwing Trade & Fast Momentum Stock Entry Tips - newser.com
Aug Opening: Can Rio Tinto Group Depositary Receipt reach resistance levels soonWeekly Market Outlook & Weekly High Return Opportunities - خودرو بانک
Is it time to cut losses on Aytu BioPharma Inc.Fed Meeting & Weekly High Potential Stock Alerts - newser.com
Death Cross: What analysts say about Aytu BioPharma Inc stockEarnings Miss & Safe Entry Point Identification - خودرو بانک
Signal Recap: Will Aytu BioPharma Inc benefit from rising consumer demandEntry Point & AI Enhanced Trading Alerts - خودرو بانک
Is Aytu BioPharma Inc. forming a reversal patternProfit Target & AI Forecasted Stock Moves - newser.com
Insider Sell: Will Aytu BioPharma Inc. benefit from government policy2025 Stock Rankings & Long Hold Capital Preservation Tips - خودرو بانک
Aytu BioPharma Inc. stock momentum explainedWeekly Market Outlook & Stepwise Trade Signal Implementation - newser.com
Published on: 2025-09-14 04:36:58 - newser.com
Price momentum metrics for Aytu BioPharma Inc. explained2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
Quantitative breakdown of Aytu BioPharma Inc. recent moveTrade Volume Report & Weekly Market Pulse Updates - Newser
quantitative breakdown of aytu biopharma inc. recent moveTrade Performance Summary & Target Return Focused Stock Picks - Newser
What Fibonacci levels say about Aytu BioPharma Inc. reboundJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
Applying Wyckoff theory to Aytu BioPharma Inc. stockTrend Reversal & Capital Protection Trade Alerts - Newser
Is Aytu BioPharma Inc. trending in predictive chart models2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Is Aytu BioPharma Inc. forming a bottoming baseJuly 2025 Gainers & Low Drawdown Investment Strategies - Newser
Using Ichimoku Cloud for Aytu BioPharma Inc. technicalsJuly 2025 Weekly Recap & High Conviction Buy Zone Alerts - Newser
Key metrics from Aytu BioPharma Inc.’s quarterly dataSell Signal & Accurate Technical Buy Alerts - Newser
Will Aytu BioPharma Inc. stock recover after recent dropBull Run & Free Long-Term Investment Growth Plans - Newser
Multi factor analysis applied to Aytu BioPharma Inc.July 2025 Catalysts & Weekly High Momentum Picks - Newser
Aytu BioPharma Inc. (NASDAQ:AYTU) Short Interest Update - Defense World
price momentum metrics for aytu biopharma inc. explainedJuly 2025 Macro Moves & Safe Capital Growth Stock Tips - Newser
Analyzing Aytu BioPharma Inc. with risk reward ratio charts2025 Market Sentiment & Risk Managed Trade Strategies - Newser
How to use a screener to detect Aytu BioPharma Inc. breakoutsJuly 2025 Levels & Low Risk High Reward Trade Ideas - Newser
Can Aytu BioPharma Inc. recover in the next quarterMarket Activity Report & Target Return Focused Stock Picks - Newser
Risk vs reward if holding onto Aytu BioPharma Inc.July 2025 Momentum & Reliable Intraday Trade Alerts - Newser
Chart overlay techniques for tracking Aytu BioPharma Inc.Market Trend Report & Fast Entry Momentum Alerts - Newser
Is Aytu BioPharma Inc. stock entering bullish territoryLong Setup & Weekly Top Performers Watchlists - Newser
Aytu Biopharma Inc Stock (AYTU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aytu Biopharma Inc Stock (AYTU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
| Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
1.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):